Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-983.8%Return on Equity
VS
Market
Sector
Industry
History
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information
Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQERNEXA THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ERNA - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 4.44M | $ -43.72M | -983.8% |
| 3/31/2025 | $ -5.95M | $ -46.11M | 0% |
| 12/31/2024 | $ 1.7M | $ -44.55M | -2619.34% |
| 9/30/2024 | $ -45.39M | $ -44.95M | 0% |
| 6/30/2024 | $ -8.53M | $ -23.94M | 0% |
| 3/31/2024 | $ -3.41M | $ -22.91M | 0% |
| 12/31/2023 | $ 2.23M | $ -21.68M | -971.07% |
| 9/30/2023 | $ 3.56M | $ -20.02M | -562.04% |
| 6/30/2023 | $ 3.87M | $ -21.75M | -562.47% |
| 3/31/2023 | $ 7.38M | $ -20.64M | -279.61% |
Key Performance Insights, Last 5 Years
- ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -1218.38%.
- Over the past 5 years, ERNEXA THERAPEUTICS INC's average ROE has been -831.3%.
- The median ROE for ERNEXA THERAPEUTICS INC during this period was -659.89%
- ERNEXA THERAPEUTICS INC reached its highest ROE over the past 5 years at -82.36%.
- The lowest ROE recorded by ERNEXA THERAPEUTICS INC in the same timeframe -2619.34%
ERNEXA THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ERNEXA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -6.03M ] / Equity [ $ 495K ]
(=) ROE [ -1218.38% ] ERNA - Return on Equity, Last 5 years
-2619.34%
Minimum
Dec 31, 2024
-82.36%
Maximum
Jun 30, 2021
-831.3%
Average
-659.89%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |